Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Apr 2007 07:01

ViaLogy PLC18 April 2007 Date: 18 April 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For Immediate Release ViaLogy PLC Board Appointment LONDON, April 18, 2007 -- ViaLogy PLC (LSE: VIY), the AIM-quoted technologycompany, today announced the appointment of Mr. Shah Talukder as executivedirector of ViaLogy with immediate effect. In addition to his appointment tothe main Board, Mr Talukder has also been appointed President and ChiefExecutive Officer of ViaLogy's wholly-owned American subsidiary, ViaLogy LLC, ofPasadena, California. Mr. Talukder comes to ViaLogy from Cisco Systems, where he was General Managerof Cisco's Safety, Security and Systems Business Unit (S3BU) where heestablished a start-up culture. Within Cisco he developed the vision,strategy, and road map for the Interoperability and Collaboration System (IPICS)family of products and applications. The system enables personnel within thesame or different agencies to communicate across previously isolated radio, IPand non-IP networks by delivering information to various types of communicationsdevices. These could range from a radio, a telephone, and an IP phone to amobile phone and a computer. At Cisco, Mr. Talukder was also instrumental in working closely with customers,industry and technology leaders, research institutions and sensor vendors todefine a vision and strategy for the Sensor Policy Manager (SPM) as a frameworkfor sensor based rapid detection and response to greatly improve the quality andspeed of information dissemination. "I am very excited at the potential of ViaLogy and I am looking forward toleading and growing the team," said Mr. Talukder. "The breadth of technologiesdeveloped by the company is extremely impressive and has a wide range ofapplications. It has the potential to become a platform for sensor and networksub-system interoperability and provide a service delivery architecture based oncustomer specific needs in such areas as Enterprise Security and Operations,Defence, Connected Real Estate, Oil and Gas, Transportation, Home Land Security,Retail and Healthcare." Mr Talukder added: "Customers and industry at large are looking for scaleablesolutions to sensor based remote monitoring, emissions mitigation, greenenvironment, physical and border security. As an example customers globally,regardless of national boundaries, whom I have met and spoken to are keenlyinterested in enhancing their capabilities to remotely monitor and respond togreenhouse gas, seismic and motion sensors, biological agents or to detectpressure in oil or gas pipelines. They want to provide the appropriateinformation within seconds, based on policy and business rules governing theincident. The information could be send to specific PC laptops, cell phones,PDAs, IP Phones, TV or digital signage etc. and could be in the form ofstandards-based video, voice and sensor data". "We are delighted that Shah Talukder has agreed to join us," said Mr. MichaelKelly, the former banker and venture capitalist who spearheaded the mergerarrangements which gave ViaLogy a public quotation on the AIM last year. "At Cisco, Shah has built, managed, and mentored teams towards industryexcellence through product innovations and delivery of solutions and has createda start-up like culture which is reflected by the wide industry acceptance ofCisco IPICS." Mr. Kelly will remain on the board of ViaLogy PLC as a non-executive director. ViaLogy PLC's Chairman, Mr. Terry Bond, stated: "During the last five yearsViaLogy has successfully developed a range of network-centric, real-time signalprocessing technology platforms for sensor applications. We are now transformingViaLogy into a product and sales centric company. Shah Talukder is the idealperson to scale and develop the vision, strategy and focused execution needed tolead ViaLogy forward". For further information please contact: ViaLogy PLCTerry Bond, Chairman - ViaLogy PLC +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy / Liam O'Donoghue +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defence andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
11th Jul 20239:33 amRNSForm 8.5 (EPT/RI) - Yourgene Health PLC
10th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
10th Jul 202311:44 amRNSForm 8.3 - Yourgene Health plc
10th Jul 202311:10 amRNSForm 8.3 - Yourgene
10th Jul 202310:10 amRNSForm 8.5 (EPT/RI)
10th Jul 20238:21 amRNSForm 8.3 - Yourgene Health PLC
7th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
7th Jul 202311:40 amRNSForm 8.5 (EPT/RI)
6th Jul 20232:00 pmRNSForm 8.3 - Yourgene Health plc
6th Jul 20231:00 pmRNSForm 8.5 (EPT/RI) - Replacement
6th Jul 202312:01 pmRNSForm 8.5 (EPT/RI)
6th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
6th Jul 20237:00 amRNSForm 8.3 - Yourgene Health PLC
5th Jul 20234:04 pmRNSForm 8.3 - Yourgene Health plc
5th Jul 20233:46 pmRNSFORM 8.3 - Yourgene Health Plc
5th Jul 20232:03 pmRNSForm 8.3 - Yourgene Health plc
5th Jul 20231:27 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc Amended
5th Jul 202312:30 pmRNSForm 8.3 - Yourgene Health Plc
5th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
5th Jul 202311:22 amRNSForm 8.3 - Yourgene Health plc
5th Jul 202311:03 amRNSForm 8.3 - YOURGENE HEALTH PLC
5th Jul 202310:33 amRNSForm 8.3 - Yourgene Health PLC
5th Jul 202310:23 amRNSForm 8.5 (EPT/RI)
4th Jul 20236:28 pmRNSForm 8.3 - Yourgene Health PLC
4th Jul 20235:41 pmRNSForm 8.3 -Yourgene Health plc
4th Jul 20234:53 pmRNSForm 8.3 - YourGene Health Plc
4th Jul 20233:57 pmRNSForm 8.3 - Yourgene Health plc
4th Jul 20232:26 pmRNSForm 8.3 - Yourgene Health plc
4th Jul 20231:56 pmRNSForm 8.3 - Yourgene Health plc
4th Jul 20231:56 pmRNSHolding(s) in Company
4th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
4th Jul 202311:57 amRNSForm 8.5 (EPT/RI)
4th Jul 20238:50 amRNSForm 8.3 - Yourgene Health PLC
3rd Jul 20234:04 pmRNSForm 8.3 - Yourgene Health PLC
3rd Jul 20237:00 amRNSRule 2.7 Announcement
13th Jun 20238:30 amRNSConditional disposal of Taiwan laboratory
6th Jun 202310:21 amRNSHolding(s) in Company
22nd May 20237:01 amRNSYGS to support MHC’s Boots agreement
22nd May 20237:00 amRNSDirectorate Change
5th May 202310:14 amRNSHolding(s) in Company
2nd May 20231:11 pmRNSHolding(s) in Company
27th Apr 20237:00 amRNSFull year unaudited trading update
18th Apr 20234:07 pmRNSHolding(s) in Company
31st Mar 20234:08 pmRNSHolding(s) in Company
24th Mar 20234:57 pmRNSHolding(s) in Company
17th Mar 20237:00 amRNSDirectorate Change
13th Mar 20237:00 amRNSStatement re. Silicon Valley Bank
21st Feb 202312:00 pmRNSChange of Website
27th Jan 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.